Dr. Deepak Birewar, founder and chairman of the dynamically growing CDMO Inventys Research, highlights the crucial importance of innovation in the company’s strategy to outperform its competition and strengthen its relationships with leading customers globally. Whether it relates to custom manufacturing or the company’s own product portfolio, Dr. Birewar moreover reveals how Inventys has consistently been able to develop and implement cutting-edge technologies at a commercial scale – at times even exceeding customers’ expectations.
Can you first introduce Inventys to our international readers, explaining its focus and key milestones reached over the past ten years?
"We are targeting WHO-GMP approval before the end of 2018."
